Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-08-01

Clinical Trial Update: Povidone-iodine 2% Eye Drop Versus Artificial Tear Drop for Treatment of Adenoviral Keratoconjunctivitis [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial evaluating povidone-iodine 2% eye drops vs artificial tears for adenoviral keratoconjunctivitis in Phase 1/2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • artificial tear drop (artificial tears)
  • povidone-iodine 2% eye drop (povidone-iodine)

Snippet

Sponsor: Farabi Eye Hospital | Conditions: Adenoviral Keratoconjunctivitis | Phase 1, Phase 2 | Status: UNKNOWN